|
06 Oct 2025 |
Max Healthcare
|
Consensus Share Price Target
|
1126.30 |
1251.21 |
- |
11.09 |
buy
|
|
|
|
|
07 Apr 2023
|
Max Healthcare
|
Motilal Oswal
|
1126.30
|
530.00
|
430.35
(161.72%)
|
Target met |
Buy
|
|
|
|
|
05 Feb 2023
|
Max Healthcare
|
Prabhudas Lilladhar
|
1126.30
|
500.00
|
435.50
(158.62%)
|
Target met |
Buy
|
|
|
|
|
03 Nov 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1126.30
|
500.00
|
462.85
(143.34%)
|
Target met |
Buy
|
|
|
|
|
13 Aug 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1126.30
|
427.00
|
396.85
(183.81%)
|
Target met |
Buy
|
|
|
|
|
11 Aug 2022
|
Max Healthcare
|
Edelweiss
|
1126.30
|
470.00
|
371.95
(202.81%)
|
Target met |
Buy
|
|
|
Continues to report robust performance
|
|
20 Jun 2022
|
Max Healthcare
|
Edelweiss
|
1126.30
|
470.00
|
362.40
(210.79%)
|
Target met |
Buy
|
|
|
Healthy ARPOB with improvement in occupancy
|
|
30 May 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1126.30
|
427.00
|
380.35
(196.12%)
|
Target met |
Buy
|
|
|
|
|
27 May 2022
|
Max Healthcare
|
Edelweiss
|
1126.30
|
470.00
|
374.65
(200.63%)
|
Target met |
Buy
|
|
|
Mixed performance amid margin improvement
|
|
15 Feb 2022
|
Max Healthcare
|
Edelweiss
|
1126.30
|
470.00
|
371.60
(203.09%)
|
Target met |
Buy
|
|
|
In-line performance with robust pickup in non-covid business
|
|
15 Nov 2021
|
Max Healthcare
|
Edelweiss
|
1126.30
|
456.00
|
363.60
(209.76%)
|
Target met |
Buy
|
|
|
Strong performance with healthy pickup in non-covid business
|